ABBVIE INC. vs. Abbott Laboratories
ABBVIE INC. and Abbott Laboratories are evenly matched on the factors we track — the better pick depends on what you're optimizing for.
Size & Scale
| ABBV | ABT | |
|---|---|---|
| Market Cap | $433.12 billion | $185.36 billion |
| Revenue (TTM) | — | $46.59 billion |
| Net Income (TTM) | — | $5.42 billion |
ABBV leads on 1 of 1 size & scale factors.
Valuation
| ABBV | ABT | |
|---|---|---|
| P/E Ratio | — | 34.67 |
| Price / Book | — | 3.58 |
| Price / Sales | — | 3.98 |
ABBV and ABT split the valuation factors evenly.
Profitability
| ABBV | ABT | |
|---|---|---|
| Net Margin | — | 11.65% |
| Return on Equity | — | 10.48% |
ABBV and ABT split the profitability factors evenly.
Dividend
| ABBV | ABT | |
|---|---|---|
| Dividend Yield | — | 2.35% |
| Payout Ratio | — | 81.55 |
ABBV and ABT split the dividend factors evenly.
Risk & Sentiment
| ABBV | ABT | |
|---|---|---|
| Short Interest | 0.85% | 0.57% |
ABT leads on 1 of 1 risk & sentiment factors.
Dig deeper: ABBV overview, ABBV financials, ABT overview, ABT financials.
Comparisons use delayed, cached fundamental data and cover only the factors shown. For informational purposes only — not investment advice.